Locomotor response to novelty correlates with the number of midbrain tyrosine hydroxylase positive cells in rats

Brain Research Bulletin

Volumn 87, Issue 1, 2012, Pages 94-102

  Jerzemowska, Grazyna ^a   Plucińska, Karolina ^a   Kulikowski, Michał ^a   Trojniar, Weronika ^a   Wrona, Danuta ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

Dopaminergic neuron morphology; High low responders to novelty; Midbrain dopaminergic system; Rats; Tyrosine hydroxylase

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL STRUCTURE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MESENCEPHALON; NONHUMAN; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; EXPLORATORY BEHAVIOR; MALE; MESENCEPHALON; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 84155164516     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.10.014     Document Type: Article

References (56)

1. Ambrosio E., Goldberg S.R., Elmer G.I. Behavior genetic investigation of the relationship between spontaneous locomotor activity and the acquisition of morphine self-administration behavior. Behav. Pharmacol. 1995, 6:229-237.
2. Badowska-Szalewska E., Klejbor I., Dziewiatkowski J., Spodnik J.H., MoryŚ J. The influence of acute and chronic open-field exposure on the hippocampal formation: an immunohistochemical study. Folia Morphol. 2006, 65:343-351.
3. Björklund A., Dunnett S. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007, 30:194-202.
4. Bobrovskaya L., Gilligan C., Bolster E.K., Flaherty J.J., Dickson P.W., Dunkley P.R. Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis. J. Neurochem. 2007, 100:479-489.
5. Bunney B.S., Grace A.A. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci. 1978, 23:1715-1728.
6. Cabib S., Orsini C., Le Moal M., Piazza P.V. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 2000, 289:463-465.
7. Chiodo L.A. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci. Biobehav. Rev. 1988, 12:49-91.
8. Chiodo L.A., Bunney B.S. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopaminergic neurons. J. Neurosci. 1985, 5:2539-2544.
9. Cools A.R., Gingras M.A. Nijmegen high and low responders to novelty: a new tool in the search after the neurobiology of drug abuse liability. Pharmacol. Biochem. Behav. 1998, 60:151-159.
10. Dai M., Tepper J.M. Do silent dopaminergic neurons exist in rat substantia nigra in vivo?. Neuroscience 1998, 85:1089-1099.
11. Dellu F., Piazza P.V., Mayo W., Le Moal M., Simon H. Novelty-seeking in rats-biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 1996, 34:136-145.
12. Deminiere J.M., Piazza P.V., Le Moal M., Simon H. Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci. Biobehav. Rev. 1989, 13:141-147.
13. Deminiere J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., Simon H. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res. 1992, 586:135-139.
14. Dietz D.M., Tapocik J., Gaval-Cruz M., Kabbaj M. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine. Physiol. Behav. 2005, 86:347-355.
15. Fischer A.D., Schafer M.K., Ferger B., Gross S., Westermann R., Weihe E., Kuschinsky K. Sensitization to the behavioural effects of cocaine: alterations in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 363:288-294.
16. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 1984, 4:2866-2876.
17. Harden D.G., Grace A.A. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment. J. Neurosci. 1995, 15:6157-6166.
18. Harden D.G., King D., Finlay J.M., Grace A.A. Depletion of dopamine in the prefrontal cortex decreases the basal electrophysiological activity of mesolimbic dopamine neurons. Brain Res. 1998, 794:96-102.
19. Hasue R.H., Shammah-Lagnado S.J. Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J. Comp. Neurol. 2002, 454:15-33.
20. Hollerman J.R., Grace A.A. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res. 1990, 533:203-212.
21. Hooks M.S., Colvin A.C., Juncos J.L., Justice J.B. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res. 1992, 587:306-312.
22. Hooks M.S., Juncos J.L., Justice J.B., Meiergerd S.M., Povlock S.L., Schenk J.O., Kalivas P.W. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J. Neurosci. 1994, 14:6144-6152.
23. Hurd Y.L., Lindefors N., Brodin E., Brene S., Persson H., Ungerstedt U., Hokfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Res. 1992, 578:317-326.
24. Kabbaj M., Akil H. Individual differences in novelty-seeking behavior in rats: a c-fos study. Neuroscience 2001, 106:535-545.
25. Kabbaj M., Devine P.D., Savage V.R., Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 2000, 20:6983-6988.
26. Kabbaj M., Norton C.S., Kollack-Walker S., Watson S.J., Robinson T.E., Akil H. Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology 2001, 158:382-387.
27. Kabbaj M., Evans S., Watson S.J., Akil H. The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences. Neuropharmacology 2004, 47:111-122.
28. Klitenick M.A., Deutch A.Y., Churchill L., Kalivas P.W. Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience 1992, 50:371-386.
29. Kumer S.C., Vrana K.E. The intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 1996, 67:443-462.
30. Lucas L.R., Angulo J.A., Le Moal M., McEwen B.S., Piazza P.V. Neurochemical characterization of individual vulnerability to addictive drugs in rats. Eur. J. Neurosci. 1998, 10:3153-3163.
31. Majkutewicz I., Cecot T., Jerzemowska G., MyŚlińska D., Plucińska K., Trojniar W., Wrona D. Lesion of the ventral tegmental area amplifies stimulation-induced Fos expression in the rat brain. Brain Res. 2010, 1320:95-105.
32. Majkutewicz I., Cecot T., Jerzemowska G., Trojniar W., Jaskulski M., Wrona D. Lesion and stimulation of the ventral tegmental area increases cholinergic activity in the rat brain. Acta Neurobiol. Exp. (Wars.) 2010, 70:28-39.
33. Miserendino M.D., Guitart X., Terwilliger R.Z., Chi S., Nestler E.J. Individual differences in locomotor activity are associated with levels of tyrosine hydroxylase and neurofilament proteins in the ventral tegmental area of Sprague-Dawley rats. Mol. Cell. Neurosci. 1993, 4:440-448.
34. Miserendino M.J., Haile C.N., Kosten T.A. Strain differences in response to escapable and inescapable novel environments and their ability to predict amphetamine-induced locomotor activity. Psychopharmacology 2003, 167:281-290.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
36. Piazza P.V., Le Moal M.L. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 1996, 36:359-378.
37. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
38. Piazza P.V., Deminiere J.M., Maccari S., Mormede P., Le Moal M., Simon H. Individual reactivity to novelty predicts probability of amphetamine self-administration. Behav. Pharmacol. 1990, 1:339-345.
39. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2088-2092.
40. Piazza P.V., Rouge-Pont F., Deminiere J.M., Kharoubi M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 1991, 567:169-174.
41. Piazza P.V., Barrot M., Rouge-Pont F., Marinelli M., Maccari S., Abrous D.N., Simon H., Le Moal M. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:15445-15450.
42. Rogue-Pont F., Piazza P.V., Kharouby M., Le Moal M., Simon H. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study. Brain Res. 1993, 602:169-174.
43. Sanchez H.L., Silva L.B., Portiansky E.L., Herenu C.B., Goya R.G., Zuccolilli G.O. Dopaminergic mesencephalic systems and behavioral performance in very old rats. Neuroscience 2008, 154:1598-1606.
44. Segal M. Rapid plasticity of dendritic spine: hints to possible functions?. Prog. Neurobiol. 2001, 63:61-70.
45. Sklair-Tavron J., Shi W., Lane S.B., Harris H.W., Bunney B.S., Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11202-11207.
46. Skriboll L.R., Grace A.A., Hommer D.W., Rehgeld J., Goldstein M., Hokfelt T., Bunney B.S. Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 1981, 6:2111-2124.
47. Spiga S., Serra G.P., Puddu M.C., Foddai M., Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur. J. Neurosci. 2003, 17:605-612.
48. Spiga S., Puddu M.C., Pisano M., Marco D. Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur. J. Neurosci. 2005, 22:2332-2340.
49. Stork O., Hashimoto T., Obata K. Haloperidol activates tyrosine hydroxylase gene-expression in the rat substantia nigra, pars reticulata. Brain Res. 1994, 633:213-222.
50. Thiel C.M., Muller C.P., Huston J.P., Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience 1999, 93:243-251.
51. Tohyama M., Takatsuji K. Atlas of Neuroactive Substances and Their Receptors in the Rat 1998, Oxford University Press, New York.
52. Verheij M.M.M., Cools A.R. Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine. J. Neurochem. 2007, 100:810-821.
53. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 1989, 40:191-225.
54. Wrona D., Jurkowski M., Luszawska D., Tokarski J., Trojniar W. The effects of lateral hypothalamic lesions on peripheral blood natural killer cell cytotoxicity in rats hyper- and hyporesponsive to novelty. Brain Behav. Immun. 2003, 17:453-461.
55. Wrona D., Jurkowski M., Tokarski J. Blood and spleen natural killer cell cytotoxicity after exposure to open field stress in rats: the effect of spontaneous locomotor activity. J. Neuroimmunol. 2004, 150:88-97.
56. Wrona D., Sukiennik L., Jurkowski M.K., Jurkowlaniec E., Glac W., Tokarski J. Effects of amphetamine on NK-related cytotoxicity in rats differing in locomotor reactivity and social position. Brain Behav. Immun. 2005, 19:69-77.